BIEL, Switzerland and BERN, Switzerland, July 11, 2025 /PRNewswire/ — As product requirements evolve, engineers and designers search for solutions that enable greater integration, miniaturization, and reliability without compromising on quality or design flexibility. 3D-MID (Three-Dimensional Mechatronic Integrated Devices) technology offers a practical solution to these challenges by integrating electronic circuits onto the surfaces of molded parts.
What is 3D-MID?
3D-MID, also known as 3D-Circuits, allows the integration of electrical circuits onto three-dimensional surfaces, eliminating the need for separate circuit boards. This approach supports the development of compact, lightweight, and highly functional products. By enabling circuitry to follow the contours of a molded part, 3D-MID opens new possibilities for design and integration.
Key Benefits of 3D-Circuits
Application Examples
Quality, Security, and Support
HARTING’s 3D-MID solutions are manufactured using certified processes and high-quality materials. We prioritize the protection of intellectual property throughout the development process, offering robust security measures and clear communication at every stage. Our all-in-one approach means you have a single point of contact from concept to production.
Learn More
If you are interested in exploring how 3D-MID technology could benefit your next project, visit www.3D-Circuits.com for detailed resources, whitepapers, and webinars. Our team is available to discuss your specific requirements and provide guidance on integrating 3D-MID into your designs.
Media Contact:
Michael Deckert
+41763242186
397857@email4pr.com
SOURCE HARTING AG – 3D-Circuits
SEATTLE, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage…
– Data support initiation of a combination cohort in the ongoing Phase 1 clinical trial…
SPRING, Texas, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc., a privately held pharmaceutical…
Ficerafusp alfa 750mg QW in combination with pembrolizumab demonstrates consistent overall response rate and safety…
TUS+VEN+AZA triplet frontline therapy demonstrates high rates of efficacy and MRD-negative remissions in newly diagnosed…
Demonstrated meaningful overall anemia responses across all patient subgroups, regardless of baseline transfusion status Anemia response…